Skip to main content

Are you working in COVID R&D?  Might you have need for a custom biospecimen collection?  The MT Group has conducted dozens of COVID biospecimen collections since the beginning of the pandemic, supporting R&D teams working on ground-breaking vaccines, anti-virals, and diagnostics.

We are now evaluating prospective studies that collect subjects:

  • With active respiratory infection symptoms (COVID, influenza, RSV)
  • Recovered from breakthrough COVID infections
  • At multiple timepoints (biospecimens, clinical metadata, or both)
  • Treated with specific therapies

Swabs, saliva, blood, serum, plasma, and other biospecimens are possible as is comprehensive clinical metadata including symptomology, co-morbidities, and vaccination history.  All prospectively collected subjects are fully consented with all use rights provided.